A phase I study of combretastatin A4 phosphate (CA4P) and bevacizumab in subjects with advanced solid tumors

Ítems similars

• Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer.
  per: Nathan, P, et al.
  Publicat: (2012)
• A phase I study of the safety, tolerability and antitumor activity of escalating doses of combretastatin A4 phosphate (CA4P) given in combination with bevacizumab to subjects with advanced solid tumors
  per: Nathan, P, et al.
  Publicat: (2007)
• Combretastatin A-4 phosphate (CA4P) carboplatin and paclitaxel in patients with platinum-resistant ovarian cancer: Final phase II trial results
  per: Zweifel, M, et al.
  Publicat: (2009)
• A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer.
  per: Rustin, G, et al.
  Publicat: (2010)
• Stimulation of Eryptosis by Combretastatin A4 Phosphate Disodium (CA4P)
  per: Elena Signoretto, et al.
  Publicat: (2016-03-01)